Fig. 3
Comparison of OS between the two groups of ESCC patients (C: Chemotherapy group, CC: Chemotherapy plus camrelizumab group)
Fig. 3 | World Journal of Surgical Oncology
Comparison of OS between the two groups of ESCC patients (C: Chemotherapy group, CC: Chemotherapy plus camrelizumab group)